Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 20
Oral Abstract

Cardiology
Session Type: Oral Abstract

Cardiology 1

Saturday, May 4, 2024
8:00 AM – 9:30 AM ET
Location: Metro Toronto Convention Centre: 606
CE: Live CME: 1.5

Disclosure(s):
Ashraf S. Harahsheh, MD, FAAP, FACC: OP2 Drugs, I serve as a scientific advisory board member of OP2 DRUGS (“OP2”). This position has no relevance to this activity (Ongoing) (Products/Services: Advisory Committee)
Enkhsaikhan Purevjav, MD, PhD, FAHA: I do not have any relevant financial / non-financial relationships with any proprietary interests.
George A. Porter, MD, PhD, Jr.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentations:

  • 8:00 AM – 8:15 AM ET
    Association between occurrence of congenital heart defects in offspring and maternal environmental factors in early pregnancy: the Japan Environment and Children's Study.

    Presenting Author: Shun Kawai (he/him/his) – Yokohama City University Hospital

  • 8:15 AM – 8:30 AM ET
    Neonatal Risk Factors for Pulmonary Vein Stenosis in Preterm Infants with Severe Bronchopulmonary Dysplasia: A Multicenter Case-Control Study of the Cardiology and Severe BPD Focus Groups of the CHNC

    Presenting Author: Shilpa Vyas-Read, MD MS (she/her/hers) – Emory University

  • 8:30 AM – 8:45 AM ET
    Cardiopulmonary bypass activates classical monocytes via shear-mediated activation of Store-Operated Calcium Entry.

    Presenting Author: Vishal Nigam, MD (he/him/his) – Seattle Children's

  • 8:45 AM – 9:00 AM ET
    Supranormal Exercise Capacity in Fontan Patients (high-performing Fontan) is Associated with Better Outcomes Post Fontan. A Fontan Outcomes Registry Using CMR Examination (FORCE) Registry Study.

    Presenting Author: Tarek Alsaied, MD, MSc, FACC – Children's Hospital of Pittsburgh

  • 9:00 AM – 9:15 AM ET
    Conditional Inactivation of ADAMTS6 Improves Aortic Wall Structure and Longevity in Mouse Models of Marfan Syndrome

    Presenting Author: Timothy J. Mead, PhD (he/him/his) – Case Western Reserve University School of Medicine

  • 9:15 AM – 9:30 AM ET
    National Trends and Neonatal Outcomes of Preterm Infants with Critical Congenital Heart Disease

    Presenting Author: Safwat Aly, MD, MSc, FACC (he/him/his) – Boston Children's Hospital